NBY

Q: What is the price of NovaBay Pharmaceuticals Inc (NBY) today?

The price of NovaBay Pharmaceuticals Inc (NBY) today is $ 1.09, with return of 0% compared to the last year. The price of NovaBay Pharmaceuticals Inc (NBY) started the year trading around $ 0.70 and today it is at $ 1.09. Follow the real-time price chart, the historical price of NovaBay Pharmaceuticals Inc (NBY) and international markets.

Q: When does NovaBay Pharmaceuticals Inc (NBY) pay dividends?

NovaBay Pharmaceuticals Inc (NBY) distributed dividends in the last year,no mês de Septemberin the month of September

Q: Is NovaBay Pharmaceuticals Inc (NBY) worth it?

Currently, NovaBay Pharmaceuticals Inc (NBY) is priced at $ 1.09, with a P/E of -0.90%, representando um desvio de -18% em relação ao seu P/L médio histórico. No último ano, a ação apresentou a variation of 0 in its price and distributed $ 2.40 in dividends, resulting in a Dividend Yield of 92.83%. The total shareholder return was 0.00%.It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Q: How can I buy NovaBay Pharmaceuticals Inc (NBY) stock?

Investing in stocks of NovaBay Pharmaceuticals Inc (NBY) can be done in two ways: by buying the stock abroad. The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

Q: How much would 100 shares of NovaBay Pharmaceuticals Inc (NBY) yield today?

The yield of NovaBay Pharmaceuticals Inc (NBY) was -7.63% in the last month, 0.00% in the last year and 0.00% in the last 5 years (already considering appreciation and dividends).In the last 12 months, the company paid a total of $ 2.40 in dividends, a Dividend Yield of 92.83%.If you wanted to buy 100 stocks of NovaBay Pharmaceuticals Inc (NBY) today, the total investment would be $ 109.00, based on the current price of $ 1.09.If past performance were to repeat, the return on your investment would be:In 1 year: $ 109.00In 5 years: $ 109.00In 10 years: $ 109.00It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

NovaBay Pharmaceuticals Inc

Price

$ 1.09

return (12m)

p/e

-0.90

p/bv

4.57

DIVIDEND YIELD

92.83%

price NBY

NBY

If you had invested

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

ago, you would now have *

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return of NBY

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-7.63%

3 months

28.20%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Fundamentals NBY

review the fundamentals of NovaBay Pharmaceuticals Inc shares

P/E

-0.90

Sector: 8.05 Industry: 8.05

P/SALES RATIO (PSR)

0.99

Sector: 2.24 Industry: 2.24

P/BV

4.57

Sector: 1.92 Industry: 1.92

DIVIDEND YIELD (DY)

92.83%

Sector: 0.75% Industry: 0.75%

ROA

-161.71%

Sector: 0.21% Industry: 0.21%

ROE

-508.48%

Sector: 5.44% Industry: 5.44%

ROIC

Sector: -138.59% Industry: -138.59%

NET MARGIN

-100.00%

Sector: 3.15% Industry: 3.15%

GROSS MARGIN

58.53%

Sector: 31.89% Industry: 31.89%

OPERATING MARGIN

-100.00%

Sector: 4.63% Industry: 4.63%

P/EBITDA

-1.56

Sector: 3.32 Industry: 3.32

P/EBIT

-1.44

Sector: 1.81 Industry: 1.81

P/ASSET

1.45

Sector: 0.96 Industry: 0.96

BVPS

0.19

Sector: 9.61 Industry: 9.61

EPS

-0.96

Sector: 0.70 Industry: 0.70

EQUITY RATIO

0.32

Sector: 0.42 Industry: 0.42

CAGR REVENUE 5 YEARS

-12.35%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

-12.57%

Sector: - Industry: -

Fundamentals NBY

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
META	25.56	7.71	30.16%	0.35%	$ 1.50 T	30.89%
INTR	16.97	1.99	11.72%	0.97%	$ 3.64 B	15.47%
PBR	5.89	1.03	17.47%	15.42%	$ 82.23 B	16.15%
PLTR	336.03	55.03	16.38%	0.00%	$ 368.08 B	28.11%
VALE	9.38	1.22	13.01%	5.93%	$ 51.61 B	14.68%
SHEL	14.64	1.20	8.23%	3.87%	$ 214.17 B	5.44%
BDORY	10.46	0.67	6.40%	7.26%	$ 23.35 B	8.83%
MAIN	9.32	1.70	18.28%	7.60%	$ 5.00 B	86.13%
STLA	2.44	0.34	13.77%	7.24%	$ 28.46 B	3.32%
ENB	23.97	2.10	8.74%	5.69%	$ 103.11 B	9.40%
NSRGY	10.36	7.21	69.57%	3.39%	$ 257.43 B	11.75%
UNH	16.48	2.74	16.62%	2.69%	$ 289.89 B	4.04%
BBSEY	7.70	5.09	66.11%	12.01%	$ 12.21 B	100.00%
SAN	10.22	1.20	11.76%	2.07%	$ 154.94 B	22.61%
TTE	10.18	1.23	12.05%	5.37%	$ 144.30 B	7.72%
ITUB	10.29	1.90	18.42%	6.80%	$ 79.40 B	27.84%
PBR-A	5.56	0.97	17.47%	12.56%	$ 77.52 B	16.15%
TD	9.40	1.54	16.36%	3.65%	$ 140.88 B	34.93%

Stock vs Index Comparison Tool

If you had invested (change) 2 years years ago, ago, you would now have

R$ 1.000,00 in PETR4 You would now have R$ 2.294,60

R$ 1.000,00 in LEVE3 You would now have R$ 5.240,60

*The value considers the reinvestment of dividends.

NBY Historical Dividends

current DY: 92.83%

5-year average DY: 92.83%

DRAG THE FRAME TO SEE MORE DATA

type	Ex - Dividend Date	payment date	value
Dividend	09/15/2025	09/29/2025	0,80000000
Dividend	09/15/2025	09/29/2025	0,80000000
Dividend	09/15/2025	09/29/2025	0,80000000

ABOUT THE COMPANY NovaBay Pharmaceuticals Inc

NovaBay Pharmaceuticals Inc

Average user rating I10

4.0 (0 people)

United States

- year

Founded:

Time since IPO - - year

-

Employees

The Company NovaBay Pharmaceuticals Inc (United States), is listed on Nasdaq with a market cap of $ 5.06 Millions, having an equity of $ 1.11 Million.

The Company está listadathe in the sector of Others and categorized in industry of Others.

In the last 12 months the Company had a revenue of $ 5.14 Millions, which generated a loss in the amount of $ -5.64 Millions.

As for its main indicators, the Company has a P/E ratio of -0.90, a P/BV ratio of 4.57 and in the last 12 months the dividend yield of NBY was at 92.83%.

The Company is traded internationally through the ticker NBY.

Market cap

$ 5.06 Millions

Equity

$ 1.11 Million

US$ 1,109,000.00

Assets

$ 3.49 Millions

US$ 3,487,000.00

Total Shares Outstanding

5.88 Millions

5,876,000

Average Daily Trading Volume

$ 8.82 Millions

US$ 8,824,690.00

Sector

Others

Industry

Others

NBY

NBY revenue and profits

Financial Results NBY

DRAG THE FRAME TO SEE MORE DATA

NBY cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

VET - Vermilion Energy Inc.

$ 9.27 --3,38% (12M)

P/E

-0.38

4.09%

NBY

NovaBay Pharmaceuticals Inc

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return of NBY

review the fundamentals of NovaBay Pharmaceuticals Inc shares

P/E

P/SALES RATIO (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

P/EBITDA

P/EBIT

P/ASSET

BVPS

EPS

EQUITY RATIO

CAGR REVENUE 5 YEARS

CAGR PROFIT 5 YEARS

If you had invested (change) 2 years years ago, ago, you would now have

current DY: 92.83%

5-year average DY: 92.83%

type

Ex - Dividend Date

payment date

value

ABOUT THE COMPANY NovaBay Pharmaceuticals Inc

NovaBay Pharmaceuticals Inc

United States

- year

-

Financial Results NBY

NBY cash flow

asset growth - NBY

NBY balance sheet

VET - Vermilion Energy Inc.

CRERF - Carrefour SA

UNH - UnitedHealth Group Incorporated

STLA - Stellantis NV

COR - Cencora Inc.

SSL - Sasol Ltd

SHEL - Shell PLC ADR

SSNLF - Samsung Electronics Co Ltd

VET - Vermilion Energy Inc.

CRERF - Carrefour SA

UNH - UnitedHealth Group Incorporated

STLA - Stellantis NV

COR - Cencora Inc.

SSL - Sasol Ltd

SHEL - Shell PLC ADR

SSNLF - Samsung Electronics Co Ltd

Frequently Asked Questions